Summation
- He went on to be Vice President of Global Customer Experience at ZOLL Medical, a leading strategic company in EMS that acquired ACSI in 2015.
- CPR-T's approach is a major opportunity to advance care and have a meaningful impact on one of the leading killers worldwide.
- Asked to share his perspective on CPR-T, Mike Black responded “I'm looking forward to advising the CPR Therapeutics team on the development of this important suite of medical technologies.
Mike Black
CPR Therapeutics, Inc. (CPR-T) is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is one of the leading causes of sudden death worldwide and there are currently no devices more effective than manual chest compressions. Intact survival after cardiac arrest is below 10% in most communities.
Dave Gaddy, CPR Therapeutic’s CEO said
“We could not be more excited to have Mike’s expertise. His background in leading the development of innovative resuscitation and EMS medical devices is uniquely strong. He was CEO of Advanced Circulatory Systems Inc. (ACSI), one of the few start-ups to innovate significantly in CPR. He went on to be Vice President of Global Customer Experience at ZOLL Medical, a leading strategic company in EMS that acquired ACSI in 2015.”
Asked to share his perspective on CPR-T, Mike Black responded “I’m looking forward to advising the CPR Therapeutics team on the development of this important suite of medical technologies. I have a long-term commitment to improving the outcome of patients suffering cardiac arrest. CPR-T’s approach is a major opportunity to advance care and have a meaningful impact on one of the leading killers worldwide.”
Dr. Paradis, CPR-T’s Founder, and Chief Medical Officer
“Mike is a great fit for helping our start-up company take on one of medicine’s most intractable problems – improving the efficacy of CPR. I genuinely believe our chances for success go up significantly having Mike in this important role.”
